Market Currents
Alimera (ALIM) fell 29% in Thursday's AH trading after the FDA failed to approve its Iluvien...
-
Monday, December 27, 2010, 8:02 AM ETAlimera (ALIM) fell 29% in Thursday's AH trading after the FDA failed to approve its Iluvien drug and asked for more info, but Oppenheimer sees the weakness as a buying opportunity and expects Iluvien to eventually be approved.
Other date
Latest Articles
